Pediatric Immunizations

  • Melvin I. Marks
Part of the Comprehensive Manuals in Pediatrics book series (CM PEDIATRICS)

Abstract

The following comments are intended as guidelines and attempt to summarize the current scientific evidence. It is almost impossible to formulate a set of recommendations for immunization that will be universally useful, as many of the situations encountered in immunization procedures cannot be predicted accurately. Geographic areas or populations of high endemicity, as well as epidemic situations, may require different immunization practices.

Keywords

Tuberculosis Polysaccharide Flare Interferon Pseudomonas 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Addiego JE, Ammann AJ, Schiffman G, et al.: Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin’s disease. Lancet ii: 450–453, 1980.Google Scholar
  2. 2.
    Alter HJ: The evolution, implications, and applications of the hepatitis B vaccine. JAMA 247: 2272–2275, 1982.PubMedCrossRefGoogle Scholar
  3. 3.
    Anderson LJ, Winkler WG: Aqueous quaternary ammonium compounds and rabies treatment. J Infect Dis 139: 494–495, 1979.PubMedCrossRefGoogle Scholar
  4. 4.
    Anderson LJ, Winkler WG, Hafkin B, et al.: Clinical experience with a human diploid cell rabies vaccine. JAMA 244: 781–784, 1980.PubMedCrossRefGoogle Scholar
  5. 5.
    Asano Y, Nakayama H, Yazaki, et al.: Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 59: 3–7, 1977.PubMedGoogle Scholar
  6. 6.
    Asano Y, Takahashi M: Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children. Pediatrics 60: 810–814, 1977.PubMedGoogle Scholar
  7. 7.
    Balagtas RC, Nelson KE, Levin S, et al.: Treatment of pertussis with pertussis immune globulin. J Pediatr 79: 203–208, 1971.PubMedCrossRefGoogle Scholar
  8. 8.
    Balfour HH, Jr: Rubella reimmunization now. Am J Dis Child 133: 1231–1233, 1979.PubMedGoogle Scholar
  9. 9.
    Banatvala JE, Best JM, O’Shea S, et al.: Rubella-immunity gap: is intranasal vaccination the answer? Lancet i: 970, 1979.Google Scholar
  10. 10.
    Barin F, Denis F, Chiron JP, et al.: Immune response in neonates to hepatitis B vaccine. Lancet i: 251–253, 1982.Google Scholar
  11. 11.
    Barin F, Yvonnet B, Goudeau A, et al.: Hepatitis B vaccine: further studies in children with previously acquired hepatitis B surface antigenemia. Infect Immun 41: 83–87, 1983.PubMedGoogle Scholar
  12. 12.
    Bass JW, Halstead SB, Fischer GW, et al.: Oral polio vaccine. Effect of booster vaccination one to 14 years after primary series. JAMA 239: 2252–2255, 1978.PubMedCrossRefGoogle Scholar
  13. 13.
    Bell TD, Chai H, Berlow B, et al.: Immunization with killed influenza virus in children with chronic asthma. Chest 73: 140–145, 1978.PubMedCrossRefGoogle Scholar
  14. 14.
    Bernard KW, Roberts MA, Sumner J, et al.: Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses. JAMA 247: 1138–1142, 1982.PubMedCrossRefGoogle Scholar
  15. 15.
    Bernard KW, Smith PW, Kader FJ, et al.: Neuroparalytic illness and human diploid cell rabies vaccine. JAMA 248: 3136–3138, 1982.PubMedCrossRefGoogle Scholar
  16. 16.
    Bernbaum J, Borian F, Anolik R, et al.: Immune response of preterm infants to diphtheria, pertussis and tetanus toxoid (DPT) vaccine. Pediatr Res 17: 223A, 1983.Google Scholar
  17. 17.
    Bernstein DI, Ogra PL: Fetomaternal aspects of immunization with RA27/ 3 live attenuated rubella virus vaccine during pregnancy. J Pediatr 97: 467–470, 1980.PubMedCrossRefGoogle Scholar
  18. 18.
    Bhandari B, Pamecha RK, Mandowara SL: Seroconversion following primary immunization with DPT vaccines: Two versus three doses. Indian J Pediatr 18: 41–47, 1981.Google Scholar
  19. 19.
    Boe E, Nyland H: Guillain-Barre’ syndrome after vaccination with human diploid cell rabies vaccine. Scand J Infect Dis 12: 231–232, 1980.PubMedGoogle Scholar
  20. 20.
    Bottiger M, Romanus V, deVerdier C, et al.: Osteitis and other complications caused by generalized BCG-itis. Acta Paediatr Scand 71: 471–478, 1982.PubMedCrossRefGoogle Scholar
  21. 21.
    Boyer KM, Theeravuthichai J, Vogel LC, et al.: Antibody response to group B Streptococcus type III and AB blood group antigens induced by pneumococcal vaccine. Pediatrics 98: 374–378, 1981.CrossRefGoogle Scholar
  22. 22.
    Broome CV, Facklam RR, Fraser DW: Pneumococcal disease after pneumococcal vaccination. An alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303: 549–552, 1980.PubMedCrossRefGoogle Scholar
  23. 23.
    Broome CV, Preblud SR, Bruner B, et al.: Epidemiology of pertussis, Atlanta, 1977. J Pediatr 98: 362–367, 1981.PubMedCrossRefGoogle Scholar
  24. 24.
    Brown AE, Steinherz PG, Miller DR, et al.: Immunization against influenza in children with cancer. Results of a 3-dose trial. J Infect Dis 145: 126–131, 1982.PubMedCrossRefGoogle Scholar
  25. 25.
    Buck BE, Yang LC, Caleb MH, et al.: Measles virus panniculitis subsequent to vaccine administration. J Pediatr 101: 366 - 373, 1982.PubMedCrossRefGoogle Scholar
  26. 26.
    Byrne EB, Rosenstein BJ, Jaworski AA, et al.: A statewide mass measles immunization program. JAMA 199: 619 - 623, 1967.PubMedCrossRefGoogle Scholar
  27. 27.
    Centers for Disease Control: Recommendations of the Public Health Service Advisory Committee on Immunization Practices. Influenza vaccine. Morbid Mortal Weekly Rep 23: 215, 1974.Google Scholar
  28. 28.
    Centers for Disease Control: Recommendation of the Public Health Service Advisory Committee on Immunization Practices. General recommendations on immunization. Morbid Mortal Weekly Rep 25: 349–355, 1976.Google Scholar
  29. 29.
    Centers for Disease Control: BCG vaccines. Morbid Mortal Weekly Rep 28: 241–244, 1979.Google Scholar
  30. 30.
    Centers for Disease Control: Epidemiologic notes and reports. Rubella vaccination and pregnancy. Morbid Mortal Weekly Rep 31: 477, 1982.Google Scholar
  31. 31.
    Centers for Disease Control: Inactivated hepatitis B virus vaccine. Morbid Mortal Weekly Rep 31: 317–328, 1982.Google Scholar
  32. 32.
    Centers for Disease Control: The safety of hepatitis B virus vaccine. Morbid Mortal Weekly Rep 32: 134–136, 1983.Google Scholar
  33. 33.
    Centers for Disease Control: Recommendation of the Immunization Practices Advisory Committee. Poliomyelitis prevention. Morbid Mortal Weekly Rep 31: 22–34, 1982.Google Scholar
  34. 34.
    Centers for Disease Control: Measles prevention. Morbid Mortal Weekly Rep 31: 217–231, 1982.Google Scholar
  35. 35.
    Centers for Disease Control: Rubella vaccination during pregnancy—United States, 1971-1982. Morbid Mortal Weekly Rep 32: 429–437, 1983.Google Scholar
  36. 36.
    Chan CC, Sogg RL, Steinman L: Isolated oculomotor palsy after measles immunization. Am J Ophthalmol 89: 446–448, 1980.PubMedGoogle Scholar
  37. 37.
    Chang TW: Rubella reinfection and intrauterine involvement. J Pediatr 84: 617–618, 1974.PubMedCrossRefGoogle Scholar
  38. 38.
    Chaves-Carballo E, Sanchez GA: Regional lymphadenitis following BCG vaccination (BCGitis). Clinical comments based upon 25 instances among 1295 childhood vaccinees. Clin Pediatr 11: 693–697, 1972.CrossRefGoogle Scholar
  39. 39.
    Cherry JD, Feigin RD, Shackelford PG, et al.: A clinical and serologic study of 103 children with measles vaccine failure. J Pediatr 82: 802–808, 1973.PubMedCrossRefGoogle Scholar
  40. 40.
    Citron ML, Moss BM: Pneumococcal vaccine-induced thrombocytopenia. JAMA 248: 1178, 1982.PubMedCrossRefGoogle Scholar
  41. 41.
    Clemens JD, Chuong JJH, Feinstein AR: The BCG controversy. A methodological and statistical reappraisal. JAMA 249: 2362–2369, 1983.PubMedCrossRefGoogle Scholar
  42. 42.
    Cody CL, Baraff LJ, Cherry JD, et al.: Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68: 650 - 660, 1981.PubMedGoogle Scholar
  43. 43.
    Cossart YE, Field AM, March SP, et al.: Latex test for Au antigen. Lancet ii: 379–382, 1972.Google Scholar
  44. 44.
    Dastur FD, Awatramani VP, Dixit SK, et al.: Response to single dose of tetanus vaccine in subjects with naturally acquired tetanus antitoxin. Lancet ii: 219–222, 1981.Google Scholar
  45. 45.
    Davis AL, Conrado A, Christianson L, et al.: Pneumococcal antibodies in patients with chronic obstructive pulmonary disease and their response to pneumococcal capsular polysaccharides: preliminary results. Rev Infect Dis 3: S183, 1981.PubMedCrossRefGoogle Scholar
  46. 46.
    Deforest A, Parker PB, Diliberti JH, et al.: The effect of breast-feeding on the antibody response of infants to trivalent oral poliovirus vaccine. J Pediatr 83: 93–95, 1973.PubMedCrossRefGoogle Scholar
  47. 47.
    DeStefano F, Goodman RA, Noble GR, et al.: Simultaneous administration of influenza and pneumococcal vaccines. JAMA 247: 2551–2554, 1982.Google Scholar
  48. 48.
    Detels R, Kim KSW, Gale JL, et al.: Viral shedding in Chinese children following vaccination with HPV-77 and Cendehill-51 live attenuated rubella vaccines. Am J Epidemiol 94: 473–478, 1971.PubMedGoogle Scholar
  49. 49.
    Editorial: Cholera vaccine and international travel. Lancet i: 1369 - 1372, 1973.Google Scholar
  50. 50.
    Editorial: Public health—further contributions to the pertussis vaccine debate. Lancet i:l 113–1114, 1981.Google Scholar
  51. 51.
    Eickhoff TC: Immunization against influenza: rationale and recommendations. J Infect Dis 123: 446–454, 1971.PubMedCrossRefGoogle Scholar
  52. 52.
    Facktor MA, Bernstein RA, Fireman P: Hypersensitivity to tetanus toxoid. J Allergy Clin Immunol 52: 1–12, 1973.PubMedCrossRefGoogle Scholar
  53. 53.
    Fayaz A, Simani S, Nour-Salehi S, et al.: Booster effect of human diploid cell antirabies vaccine in previously treated persons. JAMA 246: 2334–2335, 1981.PubMedCrossRefGoogle Scholar
  54. 54.
    Felix JK, Schwartz RH, Myers GJ: Isolated hypoglossal nerve paralysis following influenza vaccination. Am J Dis Child 130: 82–83, 1976.PubMedGoogle Scholar
  55. 55.
    Fernald GW, Glezen WP: Humoral and cellular immune responses to an inactivated Mycoplasma pneumoniae \accine in children. J Infect Dis 127: 498–504, 1973.PubMedCrossRefGoogle Scholar
  56. 56.
    Fikrig SM, Schiffman G, Phillip JC, et al.: Antibody response to capsular polysaccharide vaccine of Streptococcus pneumoniae in patients with nephrotic syndrome. J Infect Dis 137: 818–821, 1978.PubMedCrossRefGoogle Scholar
  57. 57.
    Fischer RG, Booth BH, Mitchell DQ, et al.: Influence of trivalent influenza vaccine on serum theophylline levels. Can Med Assoc J 126: 1312–1313, 1982.PubMedGoogle Scholar
  58. 58.
    Fleet WF, Schaffner W, Lefkowitz LB, et al.: Exposure of susceptible teachers to rubella vaccinees. Am J Dis Child 123: 28–30, 1972.PubMedGoogle Scholar
  59. 59.
    Fox JP: Eradication of poliomyelitis in the United States: a commentary on the Salk reviews. Rev Infect Dis 2: 277–281, 1980.PubMedCrossRefGoogle Scholar
  60. 60.
    Fulginiti VA, Helfer RE: Atypical measles in adolescent siblings 16 years after killed measles virus vaccine. JAMA 244: 804–806, 1980.PubMedCrossRefGoogle Scholar
  61. 61.
    Gard S, Lennette EH, Stuart-Harris CH, et al.: International conference on vaccines against viral and rickettsial diseases. JAMA 199: 112–115, 1967.CrossRefGoogle Scholar
  62. 62.
    Ghosh S, Mohan M, Khoche S, et al.: DTP immunization and malnutrition. Indian j Pediatr 17: 123–125, 1980.Google Scholar
  63. 63.
    Glazer JP, Friedman HM, Grossman RA, et al.: Live cytomegalovirus vac-cination of renal transplant candidates. Ann Intern Med 91: 676–683, 1979.PubMedGoogle Scholar
  64. 64.
    Grady GF: Hepatitis B immunity in hospital staff targeted for vaccination. JAMA 248: 2266–2269, 1982.PubMedCrossRefGoogle Scholar
  65. 65.
    Grob PR, Crowder MJ, Robbins JF: Effect of vaccination on severity and dissemination of whooping cough. Br Med J 282: 1925–1928, 1981.CrossRefGoogle Scholar
  66. 66.
    Gross PA, Lee H, Wolff JA, et al.: Influenza immunization in immunosuppressed children. J Pediatr 92: 30–35, 1978.PubMedCrossRefGoogle Scholar
  67. 67.
    Halsey NA, Spika JS, Lum GM, et al.: Adverse reactions to pneumococcal polysaccharide vaccine in children. Pediatr Infect Dis 1: 34–36, 1982.PubMedCrossRefGoogle Scholar
  68. 68.
    Hanissian AS, Martinez J, Jabbour JT, et al.: Vasculitis and myositis secondary to rubella vaccination. Arch Neurol 28: 202–204, 1973.PubMedGoogle Scholar
  69. 69.
    Harper JR: Anaphylactic reaction to BCG vaccination. Lancet 1: 403 - 404, 1982.PubMedCrossRefGoogle Scholar
  70. 70.
    Hattwick MAW, Rubin RH, Music S, et al.: Postexposure rabies prophylaxis with human rabies immune globulin. JAMA 227: 407–410, 1974.PubMedCrossRefGoogle Scholar
  71. 71.
    Herman JJ, Radin R, Schneiderman R: Allergic reaction to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 102: 196–199, 1983.PubMedCrossRefGoogle Scholar
  72. 72.
    Herrmann KL, Halstead SB, Wiebenga NH: Rubella antibody persistence after immunization. JAMA 247: 193–196, 1982.PubMedCrossRefGoogle Scholar
  73. 73.
    Hirschel B: Failures with oral typhoid vaccine Ty21 a. Lancet 1: 817–818, 1983.PubMedCrossRefGoogle Scholar
  74. 74.
    Hirtz DG, Nelson KB, Ellenberg JH: Seizures following childhood immunizations. J Pediatr 102: 14–18, 1983.PubMedCrossRefGoogle Scholar
  75. 75.
    Hoofnagle JH, Seeff LB, Bales ZB, et al.: Passive-active immunity from hepatitis B immune globulin. Ann Intern Med 91: 813–818, 1979.PubMedGoogle Scholar
  76. 76.
    Howells CHL, Evans AD, Vesselinova Jenkins C: Effect of two doses of influenza vaccine in stimulating antibody in volunteers. Lancet 1: 1436–1438, 1973.PubMedCrossRefGoogle Scholar
  77. 77.
    Hurwitz ES, Schonberger LB, Nelson DB, et al.: Guillain-Barre syndrome and the 1978–79 influenza vaccine. N Engl J Med 304: 1557–1561, 1981.PubMedCrossRefGoogle Scholar
  78. 78.
    Immunization Practices Advisory Committee (ACIP): Plague vaccine. Morbid Mortal Weekly Rep 31: 301–304, 1982.Google Scholar
  79. 79.
    Iwarson S, Larsson P: Intradermal versus subcutaneous immunization with typhoid vaccine. J Hyg (Lond.) 84: 11–16, 1980.CrossRefGoogle Scholar
  80. 80.
    Izawa T, Ihara T, Hattori A: Application of a live varicella vaccine in children with acute leukemia or other malignant diseases. Pediatrics 60: 805–809, 1977.PubMedGoogle Scholar
  81. 81.
    Janot C, Stoltz JF, Avenard G, et al.: Preparation of varicella-herpes zoster immunoglobulin. Transfusion 21: 732–734, 1981.PubMedCrossRefGoogle Scholar
  82. 82.
    Jhaveri R, Rosenfield W, Salazar D, et al.: High titer multiple dose therapy with HBIG in newborn infants of HB,Ag positive mothers. J Pediatr 97: 305308, 1980.Google Scholar
  83. 83.
    Johnstone DE, Douglas RG, Simon R: Attempted induction of interferon by bacterial vaccines in allergic and nonallergic humans. Ann Allergy 32: 7072, 1974.Google Scholar
  84. 84.
    Jordan MC, Rousseau WE, Tegtmeier GE, et al.: Immunogenicity of in-activated influenza virus vaccine in chronic renal failure. Ann Intern Med 79: 790–794, 1973.PubMedGoogle Scholar
  85. 85.
    Kaplan J, Frost H, Sarnaik S, et al.: Type-specific antibodies in children with sickle cell anemia given polyvalent pneumococcal vaccine. J Pediatr 100: 404406, 1982.Google Scholar
  86. 86.
    Katz SL, Krugman S, Quinn TC: International symposium on measles immunization. Rev Infect Dis 5: 389, 1983.CrossRefGoogle Scholar
  87. 87.
    Kayhty H, Karanko V, Peltola H, et al.: Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and children. J Infect Dis 142: 861–868, 1980.PubMedCrossRefGoogle Scholar
  88. 88.
    Keane JT, James K, Blankenship ML, et al.: Progressive vaccinia associated with combined variable immunodeficiency. Arch Dermatol 119: 404–408, 1983.PubMedCrossRefGoogle Scholar
  89. 89.
    Keller R, Dwyer JE, Oh W, et al.: Intestinal IgA neutralizing antibodies in newborn infants following poliovirus immunization. Pediatrics 43: 330 - 338, 1969.PubMedGoogle Scholar
  90. 90.
    Kelton JG: Vaccination-associated relapse of immune thrombocytopenia. JAMA 245: 369–371, 1981.PubMedCrossRefGoogle Scholar
  91. 91.
    Klock LE, Spruance SL, Bailey A, et al.: A clinical and serological study of women exposed to rubella vaccinees. Am J Dis Child 123: 465–468, 1973.Google Scholar
  92. 92.
    Knodell RG, Conrad ME, Ginsbey Al, et al.: Efficacy of prophylactic gammaglobulin in preventing non-A-non-B post-transfusion hepatitis. Lancet 1: 557–563, 1976.PubMedCrossRefGoogle Scholar
  93. 93.
    Koivikko A: Bacterial vaccine in childhood asthma. A double-blind study. Acta Allergy 28: 202–210, 1973.Google Scholar
  94. 94.
    Koplan JP, Schoenbaum SC, Weinstein MC, et al.: Pertussis vaccine-an analysis of benefits, risks and costs. N Engl J Med 301: 906–911, 1979.PubMedCrossRefGoogle Scholar
  95. 95.
    Kramer P, McClain CJ: Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med 305: 1262 - 1264, 1981.PubMedCrossRefGoogle Scholar
  96. 96.
    Kumudchandra JS, Freeman ME, Eisenberg C, et al.: Influenza virus immunization. Antibody response and adverse effects in children with renal disease. JAMA 239: 2559–2561, 1978.CrossRefGoogle Scholar
  97. 97.
    Landrigan PJ, Murphy KB, Meyer HM, et al.: Combined measles-rubella vaccines. Am J Dis Child 125: 65–67, 1973.PubMedGoogle Scholar
  98. 98.
    Lehner T, Russell MW, Caldwell J: Immunisation with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys. Lancet 1: 995–996, 1980.PubMedCrossRefGoogle Scholar
  99. 99.
    Levine L, Edsall G: Tetanus toxoid: what determines reaction proneness? J Infect Dis 144: 376, 1981.PubMedCrossRefGoogle Scholar
  100. 100.
    Levine MM, Edsall G, Bruce-Chwatt LJ: Live-virus vaccines in pregnancy: risks and recommendations. Lancet ii: 34–38, 1974.Google Scholar
  101. 101.
    Linnemann Jr CC, Dine MS, Roselle GA, et al.: Measles immunity after revaccination: results in children vaccinated before 10 months of age. Pediatrics 69: 332–335, 1982.PubMedGoogle Scholar
  102. 102.
    Linnemann Jr CC, First MR, Schiffman G: Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med 141: 1637–1640, 1981.PubMedCrossRefGoogle Scholar
  103. 103.
    MacKay A, Alcorn MJ, MacLeod IM, et al.: Fatal disseminated BCG infection in an 18-year-old boy. Lancet ii: 1332–1334, 1980.Google Scholar
  104. 104.
    Marine WM, Stuart-Harris C: Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine. J Pediatr 88: 26–30, 1976.PubMedCrossRefGoogle Scholar
  105. 105.
    Maupas P, Barin F, Chiron JP, et al.: Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Lancet 1: 289–292, 1981.PubMedCrossRefGoogle Scholar
  106. 106.
    McCloskey RV: Diphtheria antitoxin titers in hospital workers after a single dose of adult type diphtheria tetanus toxoid. Am J Med Sci 258: 209–213, 1969.PubMedCrossRefGoogle Scholar
  107. 107.
    McCollough RH, Glezen WP, Lamb GA, et al.: Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine. Am J Dis Child 117: 161–168, 1969.PubMedGoogle Scholar
  108. 108.
    McCormick JB, Gusmao HH, Nakamura S, et al.: Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy. J Clin Invest 65: 1141–1144, 1980.PubMedCrossRefGoogle Scholar
  109. 109.
    Medical Letter: Vaccines for respiratory infections. 8: 2–3, 1966.Google Scholar
  110. 110.
    Medical Letter: Diplovax-A new oral polio vaccine. 14: 57–60, 1972.Google Scholar
  111. 111.
    Medical Letter: Prophylaxis and treatment of tetanus and other clostridial wound infections. 15: 39–40, 1973.Google Scholar
  112. 112.
    Medical Letter: Immunizations and chemoprophylaxis for travelers. 25: 3739, 1983.Google Scholar
  113. 113.
    Meira AR: Duration of immunity after tetanus vaccination. Lancet ii:659661, 1973.Google Scholar
  114. 114.
    Michalek SM, McGhee JR, Babb JL: Effective immunity to dental caries: dose-dependent studies of secretory immunity by one administration of Streptococcus mutans to rats. Infect Immun 19: 217–224, 1978.PubMedGoogle Scholar
  115. 115.
    Miller CL, Pollock TM, Clewer ADE: Whooping cough vaccination: an assessment. Lancet ii: 510–513, 1974.Google Scholar
  116. 116.
    Miller LW, Older JJ, Drake J, et al.: Diphtheria immunization. Am J Dis Child 123: 197–199, 1972.PubMedGoogle Scholar
  117. 117.
    Minor DR, Schiffman G, McIntosh LS: Response of patients with Hodgkin’s disease to pneumococcal vaccine. Ann Intern Med 90: 887–892, 1979.PubMedGoogle Scholar
  118. 118.
    Modlin JF, Brandling-Bennett AD, Witte JJ, et al.: A review of five years’ experience with rubella vaccine in the United States. Pediatrics 55: 20–29, 1975.PubMedGoogle Scholar
  119. 119.
    Mogabgab WJ: Protective efficacy of killed Mycoplasma pneumoniae vaccine measured in large-scale studies in a military population. Am Rev Resp Dis 108: 899 - 908, 1973.PubMedGoogle Scholar
  120. 120.
    Moore DH, Shackelford PG, Robson AM, et al.: Recurrent pneumococcal sepsis and defective opsonization after pneumococcal capsular polysaccharide vaccine in a child with nephrotic syndrome. J Pediatr 96: 882–885, 1980.PubMedCrossRefGoogle Scholar
  121. 121.
    Morris D, McDonald JC: Failure of hyperimmune gammaglobulin to prevent whooping cough. Arch Dis Child 32: 236–239, 1957.PubMedCrossRefGoogle Scholar
  122. 122.
    Mosley WH, Aziz KMA, Rahman ASMM, et al.: Report of the 1966–67 cholera vaccine trial in rural East Pakistan. Bull WHO 47: 229–238, 1972.PubMedGoogle Scholar
  123. 123.
    Murray D, Ouellette M, Singer DA, et al.: Effect of pre-injection acetoaminophen vs placebo in moderating reactions to DPT vaccine. Pediatr Res 17: 225A, 1983.Google Scholar
  124. 124.
    Myers MG, Beckman CW, Vosdingh RA, et al.: Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults. JAMA 248: 2478–2480, 1982.PubMedCrossRefGoogle Scholar
  125. 125.
    National Association of State Public Health Veterinarians, Inc.: Compendium of Animal Rabies Vaccines, 1980. Part II. Vaccines marketed in the U.S.-1980. O.K. Commun Dis Bull Vol 80, 1980.Google Scholar
  126. 126.
    O’Shea S, Best JM, Banatvala JE, et al.: Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J 285: 253–255, 1982.CrossRefGoogle Scholar
  127. 127.
    Overturf GD: Sickle Cell Disease (SCD) Pneumococcal Vaccine Collaborative Study Group: Pneumococcal immunization in sickle cell disease. Pediatr Res 14: 562, 1980.Google Scholar
  128. 128.
    Park JM, Ledbetter EO, South MA, et al.: Paroxysmal supraventricular tachycardia precipitated by pertussis vaccine. J Pediatr 102: 883–885, 1983.PubMedCrossRefGoogle Scholar
  129. 129.
    Peebles TC, Levine L, Eldred MC, et al.: Tetanus-toxoid emergency boosters-A reappraisal. N Engl J Med 280: 575–581, 1969.PubMedCrossRefGoogle Scholar
  130. 130.
    Pierson CL: The use of immunotherapy for the prevention of opportunistic gram-negative infections. Surg Clin North Am 52: 1473–1981, 1972.PubMedGoogle Scholar
  131. 131.
    Phillips CF: Children out of step with immunization. Pediatrics 55: 877–881, 1975.PubMedGoogle Scholar
  132. 132.
    Plotkin SA, Katz M, Brown RE, et al.: Oral poliovirus vaccination in newborn African infants. Am J Dis Child 111: 27–30, 1966.PubMedGoogle Scholar
  133. 133.
    Poland JD, Calisher CH, Monath TP, et al.: Persistence of neutralizing antibody 30–35 years after immunization with 17D yellow fever vaccine. Bull WHO 59: 895–900, 1981.PubMedGoogle Scholar
  134. 134.
    Polk BF, Modlin JF, White JA, et al.: A controlled comparison of joint reactions among women receiving one of two rubella vaccines. Am J Epidemiol 115: 19–25, 1982.PubMedGoogle Scholar
  135. 135.
    Pollak M, Mitchell S: Early development of Negro and White babies. Arch Dis Child 49: 40 - 45, 1974.PubMedCrossRefGoogle Scholar
  136. 136.
    Prince AM: Use of hepatitis B immune globulin: reassessment needed. N Engl J Med 299: 198–199, 1978.PubMedCrossRefGoogle Scholar
  137. 137.
    Puck JM, Glezen WP, Frank AL, et al.: Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 142: 844–849, 1980.PubMedCrossRefGoogle Scholar
  138. 138.
    Ribera EF, Dutka AJ: Polyneuropathy associated with administration of hepatitis B vaccine. N Engl J Med 309: 614–615, 1983.PubMedGoogle Scholar
  139. 139.
    Robbins JB, Parke JC, Schneerson R, et al.: Quantitative measurement of “natural” and immunization-Induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res 7: 103–110, 1973.PubMedCrossRefGoogle Scholar
  140. 140.
    Robinson WS: The enigma of non-A, non-B hepatitis. J Infect Dis 145: 387–395, 1982.PubMedCrossRefGoogle Scholar
  141. 141.
    Rousseau WE, Noble GR, Tegtmeier GE, et al.: Persistence of poliovirus 8 years after immunization with live, attenuated virus vaccine. N Engl J Med 289: 1357–1359, 1973.PubMedCrossRefGoogle Scholar
  142. 142.
    Rubin RH, Sikes RK, Gregg MB: Human rabies immune globulin. JAMA 224: 871–874, 1973.PubMedCrossRefGoogle Scholar
  143. 143.
    Ruuskanen O, Salmi TT, Halonen P: Measles vaccination after exposure to natural measles. J Pediatr 93: 43–46, 1978.PubMedCrossRefGoogle Scholar
  144. 144.
    Rytel MW, Ferstenfeld JE, Rose HD, et al.: Efficacy of “mixed bacterial vaccine” in prophylaxis of acute respiratory infections: possible role of interferon. Am J Epidemiol 99: 347–359, 1974.PubMedGoogle Scholar
  145. 145.
    Sabin AB, Arechiga AF,, de Castro JF et al.: Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. JAMA 249: 2651–2662, 1983.PubMedCrossRefGoogle Scholar
  146. 146.
    Sanders DY, Cramblett HG: Antibody titers to polioviruses in patients ten years after immunization with Sabin vaccine. J Pediatr 84: 406–408, 1974.PubMedCrossRefGoogle Scholar
  147. 147.
    Schaffner W, Fleet WF, Kilroy AW, et al.: Polyneuropathy following rubella immunization. Am J Dis Child 127: 684–688, 1974.PubMedGoogle Scholar
  148. 148.
    Scheibel I, Bentzon MW, Christensen PE, et al.: Duration of immunity to diphtheria and tetanus after active immunization. Acta Pathol Microbiol Scand 67: 380–392, 1966.PubMedGoogle Scholar
  149. 149.
    Schwartz AR, Togo Y, Hornick RB: Clinical evaluation of live, oral types 1, 2, and 5 adenovirus vaccines. Am Rev Respir Dis 109: 233–238, 1974.PubMedGoogle Scholar
  150. 150.
    Sharma ON: Thrombocytopenia following measles-mumps-rubella vacci-nation in a one-year-old infant. Clin Pediatr 12: 315, 1973.Google Scholar
  151. 151.
    Smith DH, Peter G: Current and future vaccines for the prevention of bacterial diseases. Pediatr Clin North Am 19: 387–412, 1972.PubMedGoogle Scholar
  152. 152.
    Smith DH, Peter G, Ingram DL, et al.: Responses of children immunized with the capsular polysaccharide of Hemophihis influenzae type b. Pediatrics 52: 637–644, 1975.Google Scholar
  153. 153.
    Spika JS, Halsey NA, Fish AJ, et al.: Serum antibody response to pneu-mococcal vaccine in children with nephrotic syndrome. Pediatrics 69: 219–223, 1982.PubMedGoogle Scholar
  154. 154.
    Steinberg P, Horswood RL, Brunner H, et al.: Temperature-sensitive mutants of Mycoplasma pneumoniae. II. Response of hamsters. J Infect Dis 124: 179–187, 1971.PubMedCrossRefGoogle Scholar
  155. 155.
    Strom J: Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden 1959-65. Br Med J 4:320–323, 1967.Google Scholar
  156. 156.
    Szmuness W, Stevens CE, Harley EJ, et al.: Hepatitis B vaccine in medical staff of hemodialysis unit. N Engl J Med 307: 1481–1486, 1982.PubMedCrossRefGoogle Scholar
  157. 157.
    Szmuness W, Stevens CE, Harley EJ, et al.: Hepatitis B vaccine demon-stration of efficacy in a controlled clinical trial in a high-risk population in U.S. N Engl J Med 303: 833–841, 1980.PubMedCrossRefGoogle Scholar
  158. 158.
    Tabor E, Aronson DL, Gerety RJ: Removal of hepatitis -B-virus infectivity from Factor-IX complex by hepatitis-B immune-globulin. Lancet 11: 68–70, 1980.CrossRefGoogle Scholar
  159. 159.
    Thompson GR, Weiss JJ, Eloise MI, et al.: Intermittent arthritis following rubella vaccination. Am J Dis Child 125: 526, 1973.PubMedGoogle Scholar
  160. 160.
    Top Jr FH, Grossman RA, Bartelloni PJ, et al.: Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis 124: 148 - 154, 1971.PubMedCrossRefGoogle Scholar
  161. 161.
    Trevenen CL, Pagtakhan RD: Disseminated tuberculoid lesions in infants following BCG vaccination. Can Med Assoc J 127: 502–504, 1982.PubMedGoogle Scholar
  162. 162.
    Van der Does-van den Berg A, Hermans J, Nagel J, et al.: Immunity to diphtheria, pertussis, tetanus, and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy. Pediatrics 67: 222–229, 1981.PubMedGoogle Scholar
  163. 163.
    Wahdan MH, Sallam SA, Hassan MN, et al.: A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Bull WHO 55: 645–651, 1977.PubMedGoogle Scholar
  164. 164.
    Wahdan MH, Serie C, Cerisier Y, et al.: A controlled field trial of live Salmonella typhi strain Ty 21 a oral vaccine against typhoid: three-year results. J Infect Dis 145: 292–295, 1982.PubMedCrossRefGoogle Scholar
  165. 165.
    Weibel RE, Buynak EB, McLean AA, et al.: Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines (40675). Proc Soc Exp Biol Med 162: 328–332, 1979.PubMedGoogle Scholar
  166. 166.
    Weibel RE, Buynak EB, McLean AA, et al.: Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines (40967). Proc Soc Exp Biol Med 165: 260–263, 1980.PubMedGoogle Scholar
  167. 167.
    Weibel RE, Stokes Jr J, Buynak EB, et al.: Rubella vaccination in adult females. N Engl J Med 280: 682–685, 1969.PubMedCrossRefGoogle Scholar
  168. 168.
    Weibel RE, Stokes Jr J, Buynak EB, et al.: Influence of age on clinical response to HPV-77 duck rubella vaccine. JAMA 222: 805–807, 1972.PubMedCrossRefGoogle Scholar
  169. 169.
    Wilson RJ, Moss GWO, Jacobs JP, et al.: Persistence of antibody following booster dose of poliomyelitis vaccine. Can J Public Health 53: 17–21, 1962.PubMedGoogle Scholar
  170. 170.
    Woodward WE: Volunteer studies of typhoid fever and vaccines. Trans R Soc Trop Med Hyg 74: 553–556, 1980.PubMedCrossRefGoogle Scholar
  171. 171.
    Wright PF, Sell SHW, Thompson J, et al.: Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. J Pediatr 88: 31–35, 1976.PubMedCrossRefGoogle Scholar
  172. 172.
    Yeager AS, Harvey B, Crosson Jr FJ, et al.: Need for measles revaccination in adolescents: correlation with birth date prior to 1972. J Pediatr 102: 191–195, 1983.PubMedCrossRefGoogle Scholar
  173. 173.
    Young LS, Meyer RD, Armstrong D: Pseudomonas aeruginosa vaccine in cancer patients. Ann Intern Med 79: 518–527, 1973.PubMedGoogle Scholar
  174. 174.
    Zaia JA, Levin MJ, Preblud SR, et al.: Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to Varicella. J Infect Dis 147: 737–743, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1985

Authors and Affiliations

  • Melvin I. Marks
    • 1
    • 2
  1. 1.College of MedicineUniversity of OklahomaOklahoma CityUSA
  2. 2.Department of PediatricsOklahoma Children’s Memorial HospitalOklahoma CityUSA

Personalised recommendations